Member Board of Directors @ (July 2021 - April 2026)
Member Board of Directors @ (June 2023 - December 2025)
President, CEO and Co-Founder @ Gritstone bio (September 2015 - December 2024)
Board Member @ TCR² Therapeutics Inc. (December 2018 - June 2023)
Member Board Of Directors @ (November 2017 - July 2022)
Member Board Of Directors @ Epizyme (June 2014 - November 2021)
Member Board Of Directors @ Cell Design Labs (November 2015 - December 2017)
Chief Medical Officer, EVP Clinical and Pre-Clinical Development, Co-Founder @ (January 2009 - January 2015)
Chief Medical Officer @ Pharmion Inc (January 2006 - January 2008)
VP Clinical Development @ Chiron Corporation (January 2004 - January 2006)
Global Project Head @ Abbott Laboratories (January 2002 - January 2004)
Manager @ (January 1999 - January 2002)
Andrew Allen Education
University of Oxford
MA BM BCh
Imperial College London
Doctor of Philosophy (PhD)
Andrew Allen Skills
Biotechnology
Cancer
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
GCP
Hematology
Hospitals
Immunology
Life Sciences
Lifesciences
Medicine
Strategic Planning
Business Development
Research
Andrew Allen Summary
Andrew Allen, based in San Francisco, CA, US, is currently a Member Board of Directors at Cullinan Therapeutics. Andrew Allen brings experience from previous roles at Adventris Pharmaceuticals, Serif Biomedicines, Peptone and Revitope Oncology. Andrew Allen holds a MA BM BCh @ University of Oxford. With a robust skill set that includes Biotechnology, Cancer, Clinical Development, Clinical Research, Clinical Trials and more. Andrew Allen has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andrew Allen?
Find contact details for 700 million professionals.